Be Familiar With Treatments for Immune Thrombocytopenia

November 2018

The new med fostamatinib (Tavalisse, TAV-ah-lees) will bring up questions about treatment of immune thrombocytopenia (ITP).

This condition involves the body attacking and breaking down platelets...leading to an increased risk of bleeding.

ITP can be triggered by cancer, infections, or meds...or may be due to an unknown cause.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Hospital Practice Take Precautions With Flammable Meds
High-Alert Meds Know Which Meds Have Been Added to High-Alert Med Lists
Communication Personalize Care for Millennial Patients
Nutrition Omegaven Will Be a New IV Lipid Made From Fish Oil
Critical Care Be Aware of Med Considerations for ECMO Patients
Practice Combat Counterfeit Meds
Hematology & Oncology Be Familiar With Treatments for Immune Thrombocytopenia
Endocarditis Some Endocarditis Patients Will Get Shorter IV Antibiotic Courses
Transdermal Patches ZTlido Will Be the Latest Rx Lidocaine Patch
Renal & Urology Don't Be Surprised to See High Antibiotic Doses in Some Younger ICU Patients